Researcher Profile

Researcher Profile

Andry Van De Louw, MD, PhD

Andry Van De Louw, MD, PhD

Associate Professor, Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Scientific Program:Cancer Control
axv19@psu.edu

Research Interests

  • Respiratory Insufficiency
  • Mortality
  • Critical Illness
  • Intensive Care Units
  • Immunocompromised Host
  • Lung
  • Acute Myeloid Leukemia
  • Cohort Studies
  • Artificial Respiration
  • Respiration
  • Hypoxia
  • Oxygen

Recent Publications

2021

for the Efraim investigators and the Nine-I study group 2021, 'Bacteremia in critically ill immunocompromised patients with acute hypoxic respiratory failure: A post-hoc analysis of a prospective multicenter multinational cohort', Journal of Critical Care, vol. 64, pp. 114-119. https://doi.org/10.1016/j.jcrc.2021.03.014
Nine-I investigators 2021, 'Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study', The Lancet Haematology, vol. 8, no. 5, pp. e355-e364. https://doi.org/10.1016/S2352-3026(21)00060-0

2020

for the Efraim investigators and the Nine-I study group 2020, 'Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status', Annals of Intensive Care, vol. 10, no. 1, 146. https://doi.org/10.1186/s13613-020-00764-7
Lopez, R, Rello, J, Taccone, FS, Salem, OBH, Bauer, PR, Séguin, A, van de Louw, A, Metaxa, V, Klouche, K, Martin Loeches, I, Montini, L, Mehta, S, Bruneel, F, Lisboa, T, Viana, W, Pickkers, P, Russell, L, Rusinova, K, Kouatchet, A, Barbier, F, Mokart, D, Azoulay, E & Darmon, M 2020, 'Aminoglycosides in Immunocompromised Critically Ill Patients With Bacterial Pneumonia and Septic Shock: A Post-Hoc Analysis of a Prospective Multicenter Multinational Cohort', Shock (Augusta, Ga.), vol. 54, no. 6, pp. 731-737. https://doi.org/10.1097/SHK.0000000000001553
Van De Louw, A, Cohrs, A & Leslie, D 2021, 'Clinical Features and Outcome of Thrombotic Microangiopathies: Comparison between Patients with and without Malignancy', Thrombosis and Haemostasis, vol. 121, no. 5, pp. 565-572. https://doi.org/10.1055/s-0040-1720974
the Nine-i Investigators 2020, 'Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura (Intensive Care Medicine, (2019), 45, 11, (1518-1539), 10.1007/s00134-019-05736-5)', Intensive Care Medicine, vol. 46, no. 3, pp. 570-571. https://doi.org/10.1007/s00134-019-05904-7
the Nine-i Investigators 2020, 'Diagnosis of severe respiratory infections in immunocompromised patients', Intensive Care Medicine, vol. 46, no. 2, pp. 298-314. https://doi.org/10.1007/s00134-019-05906-5
Efraim investigators and the Nine-I study group 2020, 'Etiologies and Outcomes of Acute Respiratory Failure in Solid Organ Transplant Recipients: Insight Into the EFRAIM Multicenter Cohort', Transplantation proceedings, vol. 52, no. 10, pp. 2980-2987. https://doi.org/10.1016/j.transproceed.2020.02.170
Van de Louw, A, Zhu, X & Frankenfield, D 2020, 'How obesity and malnutrition interplay to affect mortality in critically ill patients with hematological malignancies: a retrospective cohort study', Leukemia and Lymphoma, vol. 61, no. 8, pp. 2027-2029. https://doi.org/10.1080/10428194.2020.1759053
Efraim investigators and the Nine-I study group 2021, 'ICU-acquired pneumonia in immunosuppressed patients with acute hypoxemic respiratory failure: A post-hoc analysis of a prospective international cohort study', Journal of Critical Care, vol. 63, pp. 243-245. https://doi.org/10.1016/j.jcrc.2020.09.027
Van De Louw, A, Cohrs, A & Leslie, D 2020, 'Incidence of sepsis and associated mortality within the first year after cancer diagnosis in middle aged adults: A US population based study', PloS one, vol. 15, no. 12 December, e0243449. https://doi.org/10.1371/journal.pone.0243449
Van de Louw, A, Zhu, X & Frankenfield, D 2020, 'Obesity and malnutrition in critically ill patients with acute myeloid leukemia: prevalence and impact on mortality', Nutrition, vol. 79-80, 110956. https://doi.org/10.1016/j.nut.2020.110956
Van de Louw, A, Twomey, K, Habecker, N & Rakszawski, K 2021, 'Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study', Annals of Hematology, vol. 100, no. 1, pp. 229-237. https://doi.org/10.1007/s00277-020-04197-x
Demoule, A, Antonelli, M, Schellongowski, P, Pickkers, P, Soares, M, Meyhoff, T, Rello, J, Bauer, PR, van de Louw, A, Lemiale, V, Grimaldi, D, Martin-Loeches, I, Balik, M, Mehta, S, Kouatchet, A, Barratt-Due, A, Valkonen, M, Reignier, J, Metaxa, V, Moreau, AS, Burghi, G, Mokart, D, Mayaux, J, Darmon, M, Azoulay, E, Amrein, K, Staundinger, T, Heinz, G, Sengölge, G, Zauner, C, Jaksch, P, Taccone, FS, Meert, AP, Benoît, D, Silva, UVA, Pierre de Moraes, AP, Lishoa, T, Salluh, J, Viana, W, Moralez, G, Correa, TD, Shah, U, Karvunidis, T, Martin, B, Russinova, K, Perner, A, Meyhoff, TS, Jonas, N, Bukan, RB, Moeller, AM, Nielsen, LB, Seguin, A, Chermak, A, Terzi, N, Vinatier, I, Wallet, F, Klouche, K, Platon, L, Gaborit, B, Barbier, F, Pène, F, Rabbat, A, Lemiale, V, N'Yunga, M, Girault, C, Lemaitre, C, Artaud-Macari, E, Bruneel, F, Moreau, AS, Kuitunen, A, Marsh, B, Misericordia, M, Mahon, AM, Cinnella, G, Cotoia, A, Riuniti, O, Montini, L, Spoelstra de Man, A, Landburg, PP, Bergmans, D, Hemelaar, P, Kaufmann, T, Barrat-Due, A, Klepstad, P, Encina, B, Moreno, G, Crespi, LS, Rodriguez-Ruiz, E, Bauer, P & Hemang, Y 2020, 'Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study', CHEST, vol. 158, no. 5, pp. 1947-1957. https://doi.org/10.1016/j.chest.2020.05.602

2019

Van De Louw, A, Mirouse, A, Peyrony, O, Lemiale, V & Azoulay, E 2019, 'Bacterial Pneumonias in Immunocompromised Patients', Seminars in Respiratory and Critical Care Medicine, vol. 40, no. 4, pp. 498-507. https://doi.org/10.1055/s-0039-1696961
for the Efraim investigators and the Nine-I study group 2019, 'Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy', European Respiratory Journal, vol. 54, no. 1, 1802442. https://doi.org/10.1183/13993003.02442-2018
On behalf of the Nine-i Investigators 2019, 'Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura', Intensive Care Medicine, vol. 45, no. 11, pp. 1518-1539. https://doi.org/10.1007/s00134-019-05736-5
Martin-Loeches, I, Lemiale, V, Geoghegan, P, McMahon, MA, Pickkers, P, Soares, M, Perner, A, Meyhoff, TS, Bukan, RB, Rello, J, Bauer, PR, Van De Louw, A, Taccone, FS, Salluh, J, Hemelaar, P, Schellongowski, P, Rusinova, K, Terzi, N, Mehta, S, Antonelli, M, Kouatchet, A, Klepstad, P, Valkonen, M, Landburg, PP, Barratt-Due, A, Bruneel, F, Pène, F, Metaxa, V, Moreau, AS, Souppart, V, Burghi, G, Girault, C, Silva, UVA, Montini, L, Barbier, F, Nielsen, LB, Gaborit, B, Mokart, D, Chevret, S & Azoulay, E 2019, 'Influenza and associated co-infections in critically ill immunosuppressed patients', Critical Care, vol. 23, no. 1, 152. https://doi.org/10.1186/s13054-019-2425-6
Domaradzki, L, Ghahramani, M, Rogers, R, Ruzieh, M, Wilson, R & de Louw, AV 2019, 'Spo2/fio2 on presentation as a predictor for early hemodynamic deterioration in intermediate risk acute pulmonary embolism', Respiratory care, vol. 64, no. 10, pp. 1279-1285. https://doi.org/10.4187/respcare.06797
Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (Grrr-OH) 2019, 'Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?', Annals of Intensive Care, vol. 9, no. 1, 25. https://doi.org/10.1186/s13613-019-0487-x

2018

Van de Louw, A, Lewis, AM & Yang, Z 2019, 'Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era: a focus on lung pathology and acute respiratory failure', Annals of Hematology, vol. 98, no. 1, pp. 119-129. https://doi.org/10.1007/s00277-018-3494-3
Van De Louw, A, Desai, RJ, Zhu, J & Claxton, D 2018, 'Characteristics of early acute respiratory distress syndrome in newly diagnosed acute myeloid leukemia', Leukemia and Lymphoma, vol. 59, no. 10, pp. 2369-2376. https://doi.org/10.1080/10428194.2018.1435874
Keefer, K, Bender, R, Liao, JJ, Sivik, J & Van De Louw, A 2018, 'Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival', Annals of Hematology, vol. 97, no. 12, pp. 2373-2380. https://doi.org/10.1007/s00277-018-3448-9
Fitzpatrick, N, Guck, D & Van De Louw, A 2018, 'Impact of Rothman index on delay of ICU transfer for hematology and oncology patients deteriorating in wards', Critical care (London, England), vol. 22, no. 1, pp. 331. https://doi.org/10.1186/s13054-018-2268-6
Carr, ZJ, Van De Louw, A, Fehr, G, Li, JD, Kunselman, A & Ruiz-Velasco, V 2018, 'Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis', BMC Research Notes, vol. 11, no. 1, 41. https://doi.org/10.1186/s13104-018-3165-4
Domaradzki, L, Gosala, S, Iskandarani, K & Van De Louw, A 2018, 'Is venous blood gas performed in the Emergency Department predictive of outcome during acute on chronic hypercarbic respiratory failure?', Clinical Respiratory Journal, vol. 12, no. 5, pp. 1849-1857. https://doi.org/10.1111/crj.12746

2017

for the Efraim investigators and the Nine-I study group 2017, 'Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study', Intensive Care Medicine, vol. 43, no. 12, pp. 1808-1819. https://doi.org/10.1007/s00134-017-4947-1
Schneider, C, Bayerl, M, Boyer, C, Desai, R, Claxton, D & Van De Louw, A 2017, 'Increased CD13 expression in acute myeloid leukemia-associated early acute hypoxic respiratory failure', American journal of respiratory and critical care medicine, vol. 196, no. 8, pp. 1077-1080. https://doi.org/10.1164/rccm.201701-0080LE

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)